EN
登录

波士顿微制造在医疗技术、电子和生命科学行业的应用同比增长30%

Boston Micro Fabrication Achieves 30% YoY Growth for Applications Across Medtech, Electronics and Life Sciences Industries

businesswire 等信源发布 2024-01-30 19:59

可切换为仅中文


BOSTON--(BUSINESS WIRE)--Boston Micro Fabrication (BMF), a leader in advanced manufacturing solutions for ultra-high precision applications, recently closed a landmark year where the company experienced 30% sales growth. BMF also secured its Series D funding, launched in new markets and expanded its San Diego Research Institute (SDRI), growing to 200+ team members globally and serving more than 1,800 companies worldwide..

波士顿--(商业新闻短讯)--波士顿微制造(BMF)是超高精度应用的先进制造解决方案的领导者,最近结束了具有里程碑意义的一年,公司销售额增长了30%。BMF还获得了D系列资金,在新市场推出,并扩大了圣地亚哥研究所(SDRI),在全球范围内拥有200多名团队成员,为全球1800多家公司提供服务。。

BMF’s growth is grounded in its unique, high precision and micro resolution 3D printing technology, Projection Micro Stereolithography (PμSL), which leverages light, customizable optics, a high-quality movement platform, and controlled processing technology to produce the highest precision at the 2μm scale.

BMF的发展基于其独特的高精度和微分辨率3D打印技术,即投影微立体光刻(PμSL),该技术利用光线、可定制光学器件、高质量运动平台和受控加工技术,在2μm范围内产生最高精度。

The company is focused on identifying unique applications for this technology using new materials such as BMF MED and Mechnano’s Formula1µ to help propel innovation across industries..

该公司专注于使用BMF MED和Mechnano的Formula1µ等新材料确定该技术的独特应用,以帮助推动各行业的创新。。

“Amid a challenging economic environment on both a global stage and for the 3D printing industry, we are very proud of the progress made over the last year to help our customers push the boundaries on what is possible with our technology. And while a lot of this success is due to strong execution from our team, much of it is based on our product-market focus and the fact that we are building a high value, differentiated business,” said John Kawola, CEO of Boston Micro Fabrication..

“在全球舞台和3D打印行业都面临着挑战性的经济环境下,我们为去年在帮助客户突破技术极限方面取得的进展感到骄傲。虽然取得的成功很大程度上归功于我们团队的强大执行力,但其中很大一部分是基于我们对产品市场的关注以及我们正在建立一个波士顿微制造公司首席执行官约翰·卡沃拉(JohnKawola)表示。。

UltraThineer: Entry into Dental Markets

UltraThineer:进入牙科市场

In 2023, BMF entered the dental market with the launch of UltraThineer, the world’s thinnest cosmetic dental veneers. Cosmetic veneers are currently pressed or milled, and intrusive preparation and grinding are usually required to ensure a good fit. With UltraThineer, this grinding is minimized or eliminated, creating a better experience for patients with less time intensive procedures for dentists..

2023年,BMF推出了世界上最薄的美容牙科贴面UltraThineer,进入牙科市场。化妆品贴面目前是压制或研磨的,通常需要进行侵入性的准备和研磨以确保良好的配合。使用UltraThineer,可以最大程度地减少或消除这种研磨,从而为患者提供更好的体验,减少牙医的时间密集型手术。。

This product is part of the company’s strategy to identify and develop high value applications where its technology platform can add unique value. Testing and development have been going well, with clearance from the US Food and Drug Administration (FDA) expected by mid-2024.

该产品是该公司识别和开发高价值应用程序战略的一部分,其技术平台可以增加独特的价值。测试和开发进展顺利,预计将于2024年年中获得美国食品和药物管理局(FDA)的批准。

“Small parts requiring very high levels of precision are difficult to prototype and manufacture, and we are continuing to address segments of the manufacturing and design market that may not be possible through other methods,” Kawola continued. “3D printing is a powerful tool here, and we’re continuing to uncover new applications for our technology.”.

卡沃拉继续说道:“需要非常高精度的小部件很难进行原型制作和制造,我们正在继续解决制造和设计市场中可能无法通过其他方法实现的细分市场。”。“3D打印在这里是一个强大的工具,我们正在继续为我们的技术发现新的应用。”。

San Diego Research Institute Supports Life Sciences

圣地亚哥研究所支持生命科学

In 2023, BMF also began research at its San Diego Research Institute, a new research and development center in San Diego, Calif., that has been formed specifically to develop and incubate end-product ideas that are uniquely enabled by BMF’s micro-3D manufacturing platform.

The first initiative underway is the development of next generation lab-on-chip structures that leverage the unique advantages of micro-3D printing for cell and tissue cultures. While the concept of a lab-on-a-chip was first introduced over 20 years ago, this new chip introduces a vascularized platform for drug discovery and cosmetic testing.

正在进行的第一项举措是开发下一代芯片实验室结构,利用微3D打印在细胞和组织培养中的独特优势。虽然芯片实验室的概念在20多年前首次引入,但这种新芯片为药物发现和美容测试引入了血管化平台。

SDRI aims to revolutionize these industries through its ongoing research and development of new production methods and advanced capabilities for these structures..

SDRI旨在通过不断研究和开发新的生产方法和这些结构的先进能力,彻底改变这些行业。。

To learn more about BMF’s latest initiatives, please visit www.bmf3d.com.

要了解更多有关BMF最新举措的信息,请访问www.bmf3d.com。

About Boston Micro Fabrication

关于波士顿微制造

Boston Micro Fabrication (BMF) enables highly precise, micro-scale 3D printing across healthcare, the life sciences, electronics, and machining industries. Using the company’s proprietary PμSL (Projection Micro Stereolithography) technology, the microArch system printers produce the industry’s most accurate and precise high-resolution 3D prints for product development, research, and industrial short run production.

波士顿微制造(BMF)能够在医疗保健、生命科学、电子和机械加工行业实现高精度、微型3D打印。Microach系统打印机使用公司专有的PμSL(投影显微立体光刻)技术,为产品开发、研究和工业短期生产生产生产业界最准确和精确的高分辨率3D打印。

Founded in 2016, BMF has offices in Boston, Shenzhen, Chongqing and Tokyo with a research and development center in San Diego. For more information on BMF please visit www.bmf3d.com or follow the company on LinkedIn..

BMF成立于2016年,在波士顿、深圳、重庆和东京设有办事处,在圣地亚哥设有研发中心。有关BMF的更多信息,请访问www.bmf3d.com或在LinkedIn上关注该公司。。